RxDoctor Payments Data

Allison Morgan, APRN

Family · Stamford, CTNPI 1144639923

Payments from drug & device makers

$655in general payments, 2019–2025

Across 31 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$140
  • E.r. Squibb & Sons, L.L.C.$111
  • Abbott$107
  • Esperion Therapeutics, Inc.$96
  • Pfizer$57
  • AstraZeneca$52
  • plus $91 from 4 others

What the payments were for

  • Food & beverage$655100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$655 in reported general payments places this provider in the 65th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$9,372
Medicare patients
34
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban251$299,641
XareltoRivaroxaban152$200,329
EntrestoSacubitril/Valsartan70$90,670
Repatha SureclickEvolocumab81$83,573
JardianceEmpagliflozin38$60,267
Praluent PenAlirocumab40$45,804
VascepaIcosapent Ethyl16$10,065
Metoprolol Succinate378$5,839
Atorvastatin Calcium395$4,874
Ezetimibe156$3,827
Rosuvastatin Calcium214$3,141
ClopidogrelClopidogrel Bisulfate145$2,309
Amlodipine-AtorvastatinAmlodipine/Atorvastatin13$2,204
Valsartan59$2,055
Ranolazine ErRanolazine18$2,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$57$299,641251 claims
NovartisEntresto$140$90,67070 claims
Boehringer IngelheimJardiance$26$60,26738 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,596 family providers in Connecticut.

Other family in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →